LOGIN  |  REGISTER
Assertio
Astria Therapeutics

Zynex Earns Prestigious 2024 Top Workplaces USA Employer Recognition Award

April 02, 2024 | Last Trade: US$8.00 1.02 -11.31

ENGLEWOOD, Colo., April 2, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced it is a recipient of the prestigious 2024 Top Workplaces USA award, featured in USA TODAY. This achievement underscores the organization's dedication to fostering a people-first workplace culture and prioritizing the employee experience.

"Being recognized as a 2024 Top Workplace is a testament to the dedication and passion of our team. Their unwavering commitment to excellence and collaborative spirit are the driving forces behind our success. This accolade reaffirms our belief that fostering a positive and supportive work environment is essential for both individual growth and organizational achievement." - Thomas Sandgaard, Founder, Chairman, and CEO.

With a history spanning 17 years, the Top Workplaces program has surveyed over 27 million employees, spotlighting culture excellence across 60 regional markets. The Top Workplaces USA designation honors the nation's employers of choice.

The national recognition celebrates organizations with 150 or more employees cultivating exceptional workplace environments. Of the more than 42,000 invited organizations, Zynex secured the award based solely on an employee engagement survey administered by Energage, the HR technology and research firm behind the Top Workplaces program. Survey results were evaluated by comparing responses to research-based statements that predict high performance against industry benchmarks.

Eric Rubino, Energage CEO, commented, "The Top Workplaces award is a badge of honor and something companies should be very proud to showcase. The people-first cultures they have built and nurtured will set them apart in a highly competitive market. These organizations represent the best of the best."

About Zynex

Zynex, founded in 1996, develops, manufactures, markets, and sells medical devices used for pain management and rehabilitation as well as non-invasive fluid, sepsis, and laser-based pulse oximetry monitoring systems for use in hospitals. For additional information, please visit: www.zynex.com.

Investor Relations Contact:
Quinn Callanan, CFA or Brian Prenoveau, CFA
MZ Group – MZ North America
This email address is being protected from spambots. You need JavaScript enabled to view it.
+949 694 9594

Assertio

Stock Quote

Featured Stock

Astria Therapeutics

Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...

CLICK TO LEARN MORE

Featured Stock

Chimerix

Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB